This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Does It Help or Hinder?

Bert M. Glaser, MD

Arch Ophthalmol. 1988;106(3):323-324.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Over the past several years we have been impressed by the large number of presentations at meetings and reports in scientific journals describing the use of intravitreal silicone oil for the treatment of complicated retinal detachments. Judging by the number of such presentations and reports, one might assume that silicone oil is of proven efficacy in the treatment of proliferative vitreoretinopathy and other retinal disorders. Indeed, in many parts of the world, silicone oil has become part of the standard care for various types of retinal detachments. Unfortunately, in spite of the extensive experience accumulated regarding the use of intravitreal silicone oil, major uncertainties have guided the Food and Drug Administration in its decision to require further clinical testing before approving silicone oil for general use within the eye. To aid the accumulation of necessary data regarding the safety and efficacy of intravitreal silicone oil, the National Eye Institute is . . . [Full Text PDF of this Article]

Author Affiliations
Baltimore

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?